Timothy Schmidt Email & Phone Number

Sarasota, FL, US

Ridgefield, Connecticut, United States

• Develop and innovate commercial strategies to drive growth of portfolio companies. Focused on building go-to-market models for a diverse health tech companies, including innovative fluid-warming devices (EMIT.
• $20MM 5-Year contact with the Department of Logistics (DoD) to supply forward bases with innovative fluid warming technologies.
• Closing capital raise for Fund 2 and began $100M capital raise for Fund 3.
• Managed channel distribution network and all other commercial aspects for portfolio.

Houston, Texas, United States

Selected to join the Board of Directors as we prepare for human trials of TP508. Initial target markets are Acute Respiratory Distress Syndrome (ARDS) and other fibrotic diseases of the lung.

Ridgefield, CT

• After reorganization, gained responsibility for merging 3 regions into one national selling respiratory products. Original team in 2019 consisted of eight direct reports and 750 sales people. Reported to the SVP.
• Launched new Respiratory franchise model focused on differentiating the respiratory portfolio in a highly competitive market. Combined respiratory sales teams from each of the former regions (North, South, and West).
• Built a culture from scratch for a new Region, formed by combining teams spread geographically across the US. Quickly focused on rapid assimilation to connect everyone to the new vision. Set a cadence for talking about.
• Achieved franchise revenue and profit targets in 2020, 2021, and 2022.
• Led reorganization to drive increased productivity (20% YoY) on targets while improving profitability.
• Modeled new leadership by regularly going on customer visits with salespeople to understand customer pain points and deliver messaging to the field. Instituted a regular internal social media presence to report on.

Ridgefield, US

• Challenged to restructure the US Commercial Organization to improve bottom-line performance. Managed a team of 135 professionals. Managed Prescription Medicines Business Unit Operational functions (Marketing and Sales.
• Achieved one-year operating income improvement of 19.5% while improving customer satisfaction by 25% from baseline after 18 months.
• Implemented Phase 1 of a new sales engagement B2B selling model. Phase 1 pilot lowered operating expenses 25%–38%.
• Developed innovation accelerator for emerging idea generation and ideation across the organization. For example, leveraged Project Management Office to reduce cycle time with medical, legal, and regulatory approval.

Ingelheim, Germany

• Start-up role to build and deliver innovative “solutions beyond the pill” in the face of margin pressure in North America, Europe, and select Emerging Markets. Initiated new relationship with large B2B entities in.
• Developed go-to-market strategy for key global accounts and oversaw implementation. Top five markets’ targeted accounts grew 15% faster than nontargeted.
• Improved customer satisfaction ranking 30% (US HIRC Study 2013).
• Devised a risk-sharing pricing and reimbursement program with entities including the UK’s National Health Service to grow business. Led to novel “Hospital to Home” program resulting in significantly lower 30-day.

Ingelheim Am Rhein, Germany

• Challenged to reshape marketing strategy after better-than-expected Phase 3 results of key asset. Successfully hired, developed, and retained a world-class team with expertise in medical marketing strategy, crisis.
• Created the global marketing strategy, aligned internal and external stakeholders, and drove implementation for the first-in-class novel oral anticoagulant (Pradaxa®) and pre-launch plan for idarucizamab (reversal.
• Awarded 2011 Best HCP and PR Campaign by Medical Marketing Manufacturers publication and 2012 Prix Galien (Germany, France) by the Galien Foundation.

Mba, Marketing

Bachelor Of Science (B.S.), Marketing/Marketing Management, General